Dear Medication Safety Colleagues,

I'd like to share an opportunity to submit a topic for the Safety and Quality Pearls session for the ASHP Midyear Clinical Meeting 2020. This is a well-attended session with outstanding tips for attendees and a rewarding opportunity to present at the Midyear. Please see more information below on how to submit your idea.
Hope to see you in New Orleans!
Kathy

Hi all -
I wanted to see what others are doing in light of the CME Bodyguard Pump Recall. We are working as fast as possible to get replacement pumps in but wasn't sure if others had completely quit using the recalled products.
Thanks-
Maria Cumpston, PharmD, CPPS
West Virginia University Hospital
Morgantown, WV

All of these assume an organization has defined a list of standardized gtt concentrations and limit to one concentrations unless there is a clinically essential need to have 2 standardized concentration of a drug -

1. For drugs in which you have more than one gtt concentration, does your organization use any associated nomenclature (e.g. standard vs. concentrated concentration)? Hesitant asking that since the terms are arbitrary vs. actual concentration values are objective - but still interested in what your practice is.

For medications that are administered at varying rates, such as IVIG or rituximab, do you put the infusions instructions in the EHR? If so, where in the order is it located? Or do you provide paper rate sheets to nursing staff to assist them with pump programming?

We are moving to EPIC and building out Willow Ambulatory. We were presented two options for how Medication Warnings can display (setting LPR 48600). The two options for are:

1) after each drug is verified before going to the next (only shows warnings relevant to that one drug)

2) after an entire work basket is verified (shows warnings relevant to every drug in the basket all at once)

Our Organization is discussing the risk - benefit of carrying two different concentrations of Atropine injection (for Cardiac Resuscitation) versus two different sizes of the same concentration.
The health system is made up of several hospitals: one is a Pediatric Specialty Hospital, the others are general hospitals treating adult, pediatric and Neonatal patients (NICU).
Basically, the pharmacies all need to come to agreement on which products to stock, and a standard process to assure the intended product is only distributed to the intended Care Area.

Hi
Wondering if anyone has undergone a recent TJC survey. Interested in their stance on electronic vs "wet" signatures in the employees file. Example would be sterile compounding requirements.
Is it necessary to have entire file in a paper folder, or is it OK to use a hybrid of password-protected retrievable databases (i.e. Simplifi 797) and a note in the file that all USP 797 requirements are maintained electronically with the employee's signed acknowledgement? Trying to conserve paper but do not want to be out of compliance while in TJC window.

Hello everyone,

I need support if any of you have updated policy or guidelines related to COVID19 patient's returned medications in your practice?
Especially medication safety officer in gulf area
Thank you for your help

Hi Everyone,

I am reaching out hoping to find out what other institutions are doing in regards to insulin dosing prior to surgeries/procedures for patients who are NPO? What methods do you use to prompt nursing to reduce the dose?

Thanks,

Derek Pohlmeyer
PGY1 Pharmacy Administration Resident, UW Medicine